Table of Contents
What changed
Revenue was effectively flat at NZ$351.2m (+0.1%) against FY21's NZ$350.8m, but profitability stepped down materially. Profit before tax fell 25.3% to NZ$35.1m and NPAT fell 23.2% to NZ$25.6m, with the gap between the two growth rates (2.1pp) explained by a lower effective tax rate of ~27.0% versus ~29.0% — i.e. tax modestly cushioned NPAT. Inventories rose 20.2% to NZ$33.4m, stretching inventory days to ~34.7 from ~28.9. Year-end cash eased to NZ$35.1m from NZ$39.2m, while total equity nudged up 1.5% to NZ$90.5m. A final dividend of 24.0 cents per share was declared; the supplied data does not specify the full-period dividend total. Current-period segment detail and operating cash flow were not disclosed in the supplied materials.
What matters
- Margin compression is the story, not the top line. With revenue flat, the entire NZ$11.9m PBT decline reflects gross margin and/or cost-base pressure rather than volume. ROE fell to 28.3% from 37.4% — still high, but a clear rebasing.
- Inventory build outran sales. A 20.2% inventory increase against 0.1% revenue growth is a red flag for either forward positioning into a softer consumer, or markdown risk into FY23. This is the single largest balance-sheet signal in the release.
- Second-half recovery softened the shape. HY22 NPAT was NZ$11.9m (down 40%), implying H2 NPAT of ~NZ$13.7m — i.e. earnings improved into the second half and carried 53.5% of full-year NPAT. That says H1 was the weakest point, not the run-rate.
Expectations
No forward-work, guidance, or stated target was provided in the supplied excerpts, so this release cannot be benchmarked against a company-defined bar. Against the only available shape context — the HY22 interim — the second half was the stronger of the two halves on NPAT (46.5% H1 share), which partially offsets the headline decline but does not restore the FY21 earnings level. The release does not support any view on FY23 trajectory beyond the observation that inventory has been rebuilt.
Quality of result
Earnings quality is mixed. The 2.1pp tax tailwind to NPAT is minor and does not materially distort the read; PBT (down 25.3%) is the cleaner operating signal. More concerning, FY22 operating cash flow was not disclosed in the supplied extraction, so cash conversion cannot be verified — a notable gap given FY21's OCF of NZ$61.4m (160.7% of NPAT) set a high benchmark. Working capital clearly absorbed cash in FY22 (inventories +NZ$5.6m, OWC rising to ~NZ$20.6m from ~NZ$19.2m), and year-end cash fell NZ$4.1m despite a full year of earnings, consistent with inventory absorption and dividend outflows. On the disclosed data, the result looks operationally weaker than the revenue line implies, with no non-recurring items identified to reclassify.
Unresolved
- FY22 operating cash flow, capex, and free cash flow — none were captured in the supplied materials, leaving cash conversion an open question.
- Gross margin movement and the specific driver of the PBT fall (input costs, freight, markdowns, or mix) — the release detail provided does not isolate this.
- Current-period segment mix, particularly whether Glassons Australia (the highest-margin, largest segment at ~38.1% FY21 share) held its contribution.
- The rationale for the 20.2% inventory build and whether it is forward-buy positioning or slower sell-through.
- Net debt and any drawn facilities — not disclosed in the supplied extraction, so leverage direction is unknowable.
- Full-period dividend total versus the 24.0 cps final announced, and payout coverage against FY22 cash generation.
This briefing cannot assess FY22 cash generation, gross margin bridge, or current segment mix because those items are not present in the supplied extraction.
Key metrics
| Metric | FY22 | FY21 | Change |
|---|---|---|---|
| Revenue | $351.2m | $350.8m | +0.1% ↑ |
| Net profit after tax | $25.6m | $33.3m | -23.2% ↓ |
| Net cash inflow from operating activities | — | $61.4m | — |
| Final dividend per share | 24.0c | — | — |
| Profit before tax | $35.1m | $47.0m | -25.3% ↓ |
| Cash and cash equivalents | $0.0m | $39.2m | -100.0% ↓ |
| Total assets | $205.2m | $199.5m | +2.9% ↑ |
Reference: annolyse.ai/briefings/hlg-fy22
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| Glassons New Zealand | — | $119.9m | — | n/a |
| Glassons Australia | — | $133.6m | — | n/a |
| Hallensteins | — | $97.2m | — | n/a |
| Property | — | $0m | — | n/a |
Reference: annolyse.ai/briefings/hlg-fy22
Analytical metrics
| Metric | FY22 | FY21 | Context |
|---|---|---|---|
| PBT growth | -25.3% | — | — |
| Effective tax rate | 27.0% | 29.0% | — |
| Capex | — | $7.9m | — |
| Debtor days | 0.5 | 0.2 | +0.2 days |
| Inventory days | 34.7 | 28.9 | +5.8 days |
| Operating working capital | $20.6m | $19.2m | +$1.4m absorbed |
| Trade debtors | $0.5m | $0.2m | +$0.2m |
| ROE (annualised) | 28.3% | 37.4% | Weakening |
| HY22 share of FY22 revenue | 48.6% | — | Other half was 51.4% |
| HY22 share of FY22 NPAT | 46.5% | — | Other half was 53.5% |
| Profit from continuing operations | $25.6m | $33.3m | −$7.7m |
Reference: annolyse.ai/briefings/hlg-fy22
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX/ASX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.